The Patent Finder

Yuhan Corporation

60 patents currently held · Updated Nov 17, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Process For Preparing Aminopyrimidine Derivatives (US 11,708,362) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 2 fees due Feb 1 to 20, 2027 · next Feb 1
  • 1 fee due Apr 10, 2027
    The maintenance fee for Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same (US 11,780,830) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 1 fee due May 21, 2027
    The maintenance fee for Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same (US 11,820,769) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 1 fee due Jun 26, 2027
    The maintenance fee for Therapies with 3RD Generation Egfr Tyrosine Kinase Inhibitors (US 11,850,248) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same (US 10,562,865) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 1 fee due Sep 5, 2027
    The maintenance fee for Antigen Binding Proteins that Bind PD-L1 (US 11,919,952) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
  • 1 fee due Oct 2, 2027
    The maintenance fee for Substituted Aminopyridine Compounds as Egfr Inhibitors (US 11,945,798) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
  • 2 fees due Nov 5 to 14, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 4 of the patents on this record were granted since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,476,432Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,640,490Diaminopyrimidine derivatives and processes for the preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,227,330Diaminopyrimidine Derivatives and Processes for the Preparation Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,850,227Diaminopyrimidine derivatives and processes for the preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,376,4204,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,890,138Diaminopyrimidine derivatives and processes for the preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,663,495Triazolone derivatives or salts thereof and pharmaceutical composition comprising the same
In force
 · From the USPTO record
In forceFrom the USPTO record
US RE50,528Compounds and Compositions for Modulating Egfr Mutant Kinase Activities
In force
 · Low confidence
In forceLow confidence
US 10,035,855Antibody Therapeutics That Bind CD47
In force
 · High confidence
In forceHigh confidence
US 11,142,557Long-Acting FGF21 Fusion Proteins and Pharmaceutical Composition Comprising Same
In force
 · High confidence
In forceHigh confidence
10 of 60 patents shown.
Pro members see all 60.
Pro members: see all 60 patents
Also on record, not counted in the 60: 4 patents in force now held by others · 32 lapsed for an unpaid fee · 12 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 3 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited